Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
Oct 16, 2025

‘First published on Lexology’ By: Safir Anand and Omesh Puri The Office of the Controller General of Patents, Designs, and Trade Marks has issued a

Indian Trade Marks Office issues Office Order – Streamlining Registry Function
News & Updates
Oct 16, 2025

Being a part of the International Trademarks Association (INTA) is always a delight. Here’s how Anand and Anand would be joining forces with INTA on

Team Anand and Anand for INTA
Thought Leadership
Oct 14, 2025

‘First published on Lexology’ By: Safir Anand and Arpita Mukherjee When WeWork faced turmoil globally, leading its U.S. parent company to file for

WeWork India’s NSE Listing: A Lesson in Local Execution Within Global Brands
Thought Leadership
Oct 02, 2025

‘First published on India Business Law Journal’ By: Pravin Anand and Dr. Ajai Garg The fourth industrial revolution, driven by artificial intelligence

Independent AI key to India’s global power